An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth

Vania Vidimar, Greg L. Beilhartz, Minyoung Park, Marco Biancucci, Matthew B. Kieffer, David R. Gius, Roman A. Melnyk, Karla J.F. Satchell

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry